With President Donald Trump back in the White House, several American doctors are welcoming the new administration’s greater ...

Then we have Singapore. Apparently, 11.6 per cent of our population are overweight. We are tied in third place with Thailand.

Research has found that GLP-1 receptors, found in medications like Wegovy and Monjaro, may offer health benefits beyond the ...

Ozempic was first approved to treat diabetes in Canada seven years ago. Now the largest study of its kind suggests it and other medications like it have a host of other potential health benefits ...

Study projects rising breast cancer cases in India, with an estimated annual economic burden of $19.55 billion by 2030.

Rhythm Pharmaceuticals (NASDAQ:RYTM) reported its third-quarter 2024 earnings, highlighting a steady increase in revenue and strategic developments in product innovation and market expansion. Despite ...

Obesity is a global public health problem, with rates steadily increasing in many regions of the world. However, the impact ...

Adding time-restricted eating to usual care didn't offer extra benefits in reducing visceral fat but lowered subcutaneous fat ...

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health ...

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...